Chart of the Week: Check out how ASEAN medical devices is facing a surplus bubble | Healthcare Asia Magazine
, Singapore

Chart of the Week: Check out how ASEAN medical devices is facing a surplus bubble

Trade liberalisation is causing supply to skyrocket, analysts say.

Looser trade has cemented the Southeast Asian region’s reputation as a medical device distribution centre, amassing a trade surplus reaching USD3.1b the previous year.

According to a report by BMI Research, surpluses for Singapore, Malaysia, Philippines and Vietnam however, were offset by deficits for other ASEAN members, notably Indonesia.

“We note that the trade surpluses for Malaysia and Singapore have grown at a 2010-2015 CAGR of more than 20%. This reflects growing distribution and manufacturing activity by medical device multinationals,” the report noted.

In Singapore, BMI Research said the government has been active in promoting the local manufacturing industry establishing the Centre for Biomedical Material Applications & Technology (BIOMAT) as early as 1995.

“Government incentives to attract companies to locate their manufacturing operations in Singapore include a tax-relief period when companies start up, a low rate of corporation tax, R&D and manufacturing grants and grants for training staff at new manufacturing sites,” BMI Research added.

The Malaysian Investment Development Authority (MIDA) is also promoting areas such as electrodiagnostic equipment, cardiovascular devices and orthopaedics.

“Meanwhile the trade balance for the Philippines and Vietnam has moved from deficit to surplus due to manufacturing activities within the consumables product area, notably syringes and needles for the Philippines, and catheters & cannulae for Vietnam. Multinationals with manufacturing operations include B. Braun and Terumo,” the report added.
 

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

Kejeniusan dalam ‘SuperApps’ untuk perawatan kesehatan adalah akses dan jangkauan

Rumah sakit yang merangkul digitalisasi tetap unggul dalam layanan kesehatan.

Rumah Sakit Kanker Dharmais memimpin inovasi pelayanan kanker di Indonesia

Direktur Utama RS Kanker Dharmais Soeko Werdi Nindito Daroekoesoemo mengungkapkan teknologi canggih dan tujuh program unggulan untuk perawatan kanker.

Healthway Cancer Care Hospital memajukan perawatan holistik dengan harga yang wajar

Rumah sakit mengharapkan program kualitas dan kelangsungan hidup yang melayani keseluruhan perjalanan pasien.

MakatiMed menuju perawatan bedah presisi dengan sistem robotik Da Vinci Xi

Teknologi ini memungkinkan teknik invasif minimal dalam bidang urologi, hepatobilier, kardiovaskular, toraks, kebidanan dan ginekologi, serta bedah umum.

Indonesia memperluas dukungan solusi kesehatan menggunakan AI

Kolaborasi dengan Google Cloud sejalan dengan cetak biru pemerintah untuk transformasi kesehatan digital.

Indonesia merancang rencana induk untuk pengembangan kesehatan terpadu

Rencana induk sektor kesehatan negara (RIBK) selaras dengan mandat Undang-Undang Kesehatan Nomor 17 Tahun 2023.

The Medical City membuka jalan bagi integrasi AI dalam layanan kesehatan lokal dan penelitian dengan Lunit

AI telah diintegrasikan ke dalam layanan mamografi dan rontgen dada di jaringan rumah sakit ini.

Mayapada Healthcare Group meraih prestasi besar di Healthcare Asia Awards 2024

Pendekatan holistik yang dilakukan oleh rumah sakit tersebut mendorongnya maju dan menjadi standar industri.

Rumah Sakit Kanker Dharmais meraih dua kemenangan di Healthcare Asia Awards 2024

Sumber daya manusia yang kompeten, layanan, fasilitas, dan infrastruktur unggul membantu rumah sakit memberikan perawatan pasien yang sangat baik.